Skip to main content
Terug
Watch Compare

NP Life Sciences Health Industry Group Inc.

Datakwaliteit: 100%
ACAT
OTC Services Educational Services
€ 1,00
▼ € 9,00 (-90,00%)
Marktkapitalisatie: 77,21 M
Prijs
€ 1,00
Marktkapitalisatie
77,21 M
Dagbereik
€ 1,00 — € 1,00
52-Weeksbereik
€ 0,54 — € 10,00
Volume
2.500
Openen € 1,00
50D / 200D Gem.
€ 10,00
90,00% below
50D / 200D Gem.
€ 6,07
83,54% below

Quick Summary

Belangrijkste Punten

ROE of 58,71% indicates high profitability
Generating 55.238,0 in free cash flow
P/E of 2660,93 — premium valuation
Cash machine — converts 190,36% of earnings into free cash flow
ROIC of 34,16% — excellent capital efficiency

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-38,04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
58,71%
Boven sectorgemiddelde (-1,53%)
ROIC34,16%
Net Margin14,46%
Op. Margin25,80%

Veiligheid

Debt / Equity
N/A
Current RatioN/A
Interest Coverage12943,00

Waardering

PE (TTM)
2660,93
Boven sectorgemiddelde (-0,01)
P/B Ratio2433,04
EV/EBITDA1489,81
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (20 peers)
Metriek Aandeel Sector Mediaan
P/E 2660,9 0,0
P/B 2433,0 3,1
ROE % 58,7 -1,5
Net Margin % 14,5 -0,3
Rev Growth 5Y % — 19,1
D/E — 1,0

All Fundamental Metrics
Growth
Revenue Growth (1Y) -38,04% Revenue Growth (3Y) 70,73%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200.634,0 Net Income (TTM) 29.018,0
ROE 58,71% ROA 24,24%
Gross Margin N/A Operating Margin 25,80%
Net Margin 14,46% Free Cash Flow (TTM) 55.238,0
ROIC 34,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage 12943,00 Asset Turnover 1,68
Working Capital N/A Tangible Book Value 31.736
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2660,93 Forward P/E N/A
P/B Ratio 2433,04 P/S Ratio 384,85
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1489,81 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,07%
Market Cap 77,21 M Enterprise Value 77,13 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 190,36%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Revenue 102.002,0 164.621,0 34.992,0 15.000,0 43.000,0
Net Income -18.856,0 -2.935,0 -65.677,0 -131.065,0 -108.827,0
EPS (Diluted) — 0,00 — — —
Gross Profit — — — — —
Operating Income -18.855,0 -690,0 -65.681,0 -131.091,0 -108.859,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -1,0 645,0 — — —
Income Tax — 1.600,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Total Assets 127.784,0 76.864,0 38.411,0 118.611,0 250.097,0
Total Liabilities 108.468,0 60.483,0 239,0 14.762,0 15.183,0
Shareholders' Equity 19.316,0 16.381,0 38.172,0 103.849,0 234.914,0
Total Debt — — — — —
Cash & Equivalents 121.859,0 70.614,0 27.986,0 118.611,0 242.933,0
Current Assets — — — — —
Current Liabilities — 38.121,0 — — —